Transplantation Disease Transmission Recruiting Phase 4 Trials for Velpatasvir (DB11613)

IndicationStatusPhase
DBCOND0112917 (Transplantation Disease Transmission)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03619837Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney TransplantOther